21![Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology](https://www.pdfsearch.io/img/9e23a51cdcd9d21dc0d4f962918afa95.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
22![Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology](https://www.pdfsearch.io/img/3b6a4293e85fab5fec806bf0d06e51ef.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
23![Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Date: Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Date:](https://www.pdfsearch.io/img/76ce198a34c8417c646fc1adbad630f9.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
24![SUPRANE (desflurane, USP) Rx only Volatile Liquid for Inhalation DESCRIPTION SUPRANE (desflurane, USP), a nonflammable liquid administered via vaporizer, is a general inhalation anesthetic. It is (±)1,2,2,2-tetrafluoroe SUPRANE (desflurane, USP) Rx only Volatile Liquid for Inhalation DESCRIPTION SUPRANE (desflurane, USP), a nonflammable liquid administered via vaporizer, is a general inhalation anesthetic. It is (±)1,2,2,2-tetrafluoroe](https://www.pdfsearch.io/img/ad580f6274171a49a42c5b4d83318ed3.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-04-23 07:32:46
|
---|
25![510(k) SUMMARY KI103604[removed]k) Owner Name and Address: PHASEIN AB Svardvagen[removed]Danderyd 510(k) SUMMARY KI103604[removed]k) Owner Name and Address: PHASEIN AB Svardvagen[removed]Danderyd](https://www.pdfsearch.io/img/c73d859f9db7eb0f9d2dce33f9782eea.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2011-05-30 00:44:12
|
---|
26![ULTANE®(sevoflurane)volatile liquid for inhalation Revision Date: [removed]ULTANE® (sevoflurane) ULTANE®(sevoflurane)volatile liquid for inhalation Revision Date: [removed]ULTANE® (sevoflurane)](https://www.pdfsearch.io/img/43d078e602c2da32b59229e2fd370a1d.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:53:34
|
---|
27![ULTANE® (sevoflurane) volatile liquid for inhalation ULTANE® (sevoflurane) volatile liquid for inhalation](https://www.pdfsearch.io/img/89c7cbf267fa92e69a8614dd8442b4b6.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-03-13 16:04:48
|
---|
28![Suprane (desflurance) liquid inhalation Suprane (desflurance) liquid inhalation](https://www.pdfsearch.io/img/401ea8f0a0343c81f723d7d307e67dd3.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-09-24 10:01:30
|
---|
29![Orthro Tri-Cyclen presentation June9.ppt Orthro Tri-Cyclen presentation June9.ppt](https://www.pdfsearch.io/img/7fd209647377b498758717bebb301354.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2008-03-31 14:45:53
|
---|
30![A ABBOTT 200 Abbott Park Road Abbott Park, IL 60064 A ABBOTT 200 Abbott Park Road Abbott Park, IL 60064](https://www.pdfsearch.io/img/43843f59ad0e6045d3f68d51172b7c39.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|